Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 8, 1999, Pages 1611-1615

  Gamble, William R ^a   Durso, Neil A ^a   Fuller, Richard W ^a   Westergaard, Chandra K ^a   Johnson, Tanya R ^a   Sackett, Dan L ^a   Hamel, Ernest ^a   Cardellina II, John H ^a   Boyd, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antimitotic agents; Antitumor compounds; Marine metabolites; Natural products; Peptides

Indexed keywords

ANTINEOPLASTIC AGENT; HEMIASTERLIN; HEMIASTERLIN A; HEMIASTERLIN C; PEPTIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; EXTRACT; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPONGE; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OLIGOPEPTIDES; PORIFERA; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0032769659     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00089-9     Document Type: Article

References (19)

1. Boyd, M. R.; Paull, K. Drug Dev. Res. 1995, 34, 91.
2. Tada, H.; Yasuda, F. Chem. Lett. 1984, 779.
3. Shmueli, U.; Carmely, S.; Groweiss, A.; Kashman, Y. Tetrahedron Lett. 1981, 22, 709.
4. Carmely, S.; Loya, Y.; Kashman, Y. Tetrahedron Lett. 1983, 24, 3673.
5. Carmely, S.; Kashman, Y. J. Org. Chem. 1983, 48, 3517.
6. Carmely, S.; Kashman, Y. J. Org. Chem. 1986, 51, 784.
7. Crews, P.; Farias, J. J.; Emrich, R.; Keifer, P. A. J. Org. Chem. 1994, 59, 2932.
8. Talpir, R.; Benayahu, Y.; Kashman, Y.; Pannell, L.; Schleyer, M. Tetrahedron Lett. 1994, 35, 4453.
9. Coleman, J. E.; de Silva, E. D.; Kong, F.; Andersen, R. A. Tetrahedron 1995, 51, 10653.
10. Chan, W. R.; Tinto, W. F.; Manchand, P. S.; Todaro, L. J. J. Org. Chem. 1987, 52, 3091.
11. de Silva, E. D.; Andersen, R. A.; Allen, T. M. Tetrahedron Lett. 1990, 31, 489.
12. Anderson, H. J.; Coleman, J. E.; Andersen, R. J.; Roberge, M. Cancer Chemother. Pharmacol. 1997, 39, 223.
13. Ireland, C. M. Presented at the Fourth Anticancer Drug Discovery and Development Symposium, Annapolis, MD, 1997.
14. Bai, R.; Pettit, G. R.; Hamel, E. J. Biol. Chem. 1990, 265, 17141.
15. Smith, C. D.; Zhang, X. J. Biol. Chem. 1996, 271, 6192.
16. Bai, R.; Schwartz, R. E.; Kepler, J. A.; Pettit, G. R.; Hamel, E. Cancer Res. 1996, 56, 4398.
17. Bai, R.; Friedman, S. J.; Pettit, G. R.; Hamel, E. Biochem. Pharmacol. 1992, 43, 2637.
18. Wetlaufer, D. B. Adv. Protein Chem. 1962, 17, 303.
19. Verdier-Pinard, P.; Lai, J.-Y.; Yoo, H.-D.; Yu, J.; Marquez, B; Nagle, D. G.; Nambu, M.; White, J. D.; Falck, J. R.; Gerwick, W. H.; Day, B. W.; Hamel, E. Mol. Pharmacol. 1998, 53, 62.